The Russian scientist Mikhail Blagosklonny a native of St. Petersburg and earned a university education in that Russian city.He is focused on helping fight cancer and using his knowledge to change the treatment that is currently used in treatment of the disease. This is the professional credited with advocating for rampaycin. It is known as an anti-cancer drug along with some interesting properties. This is an anticancer drug with properties for an anti-aging drug. He realized while working on cancer treatments during the early 2000’s the drug had some properties that could slow tumor growth. Mr. Blagosklonny is at Roswell Park Cancer Institute in Buffalo where he continues to focus on the study of cancer and aging.The goal he has set is to figure out how to treat cancer in a manner that is not painful or expensive. He believes in the future the luxury type of care available that only people with money can afford instead it will be a cost effective treatment that will be easy on the body. This will not be like current treatments, but instead a way to eliminate cancer cells while the normal cells are unharmed.
This would be a total change in the way cancer is treated and the harsh effects on the body. His interests in the research involve the cellular and molecular biology, signal transduction, cell cycle, cellular senescence, and clinical investigations for anti-cancer therapeutics.Mikhail Blagosklonny was so confident in the use of rapamycin that he took it himself saying it is more dangerous not to take it. Then compared what would be dangerous that included overeating, smoking or driving without using a seatbelt. Since this time the drug is credited with having shown to improve the immunity in older adults, which also gave it the anti-aging label.St. Petersburg, Russia. He was appointed an associate professor at the New York Medical College in Valhalla. Mr. Blagosklonny worked at the Ordway Research Institute in Albany as a senior scientist and later took a position as professor of oncology at Roswell Park Cancer Institute.
After taking this position he said that the future of cancer research will be in the hands of future scientists and medical professionals. This will include the future treatment of cancer patients and how cells are looked at by scientists.Mikhail Blagosklonny, M.D., has nearly two hundred research articles book chapters published in this field. Cell Cycle is a publication the doctor serves as an editor of the publication, though it is just one of several. He is active in these publications to bring more information to the medical community about cancer. He serves as an associate editor of several other medical publications that he serves as editor or associate editor. Some of the publications he serves as associate editor include Autophagy International Journal of Cancer, and the American Journal of Pathology. He believes this is research that may change the way the disease is looked at by medical professionals and the treatments they have available.